GKIM
SYNH

GW&K Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

GW&K Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-125
Closed -$6K – 944
2023
Q2 		$6K Sell
125
-279
-69% -$11.3K ﹤0.01% 779
2023
Q1 		$14K Sell
404
-629,313
-100% -$22.8M ﹤0.01% 387
2022
Q4 		$23.1M Sell
629,717
-810,994
-56% -$32.1M 0.23% 161
2022
Q3 		$67.9M Buy
1,440,711
+66,911
+5% +$4.32M 0.75% 26
2022
Q2 		$98.5M Sell
1,373,800
-39,034
-3% -$2.85M 1.06% 6
2022
Q1 		$114M Sell
1,412,834
-199,084
-12% -$16.8M 1.02% 11
2021
Q4 		$166M Buy
1,611,918
+31,598
+2% +$3.03M 1.38% 2
2021
Q3 		$138M Sell
1,580,320
-94,297
-6% -$8.54M 1.24% 4
2021
Q2 		$150M Buy
1,674,617
+14,260
+0.9% +$1.2M 1.3% 1
2021
Q1 		$126M Buy
1,660,357
+101,929
+7% +$7.68M 1.16% 3
2020
Q4 		$106M Buy
1,558,428
+39,124
+3% +$2.44M 1.11% 5
2020
Q3 		$80.8M Buy
1,519,304
+123,927
+9% +$7.38M 1.06% 6
2020
Q2 		$81.3M Buy
1,395,377
+405,157
+41% +$21.8M 1.14% 4
2020
Q1 		$39M Sell
990,220
-104,342
-10% -$6.1M 0.69% 35
2019
Q4 		$65.1M Sell
1,094,562
-31,235
-3% -$1.68M 0.87% 19
2019
Q3 		$59.9M Buy
1,125,797
+213,112
+23% +$10.9M 0.84% 19
2019
Q2 		$46.6M Sell
912,685
-19,470
-2% -$907K 0.71% 26
2019
Q1 		$48.2M Sell
932,155
-34,635
-4% -$1.68M 0.78% 27
2018
Q4 		$38M Sell
966,790
-46,947
-5% -$2.18M 0.75% 33
2018
Q3 		$52.3M Buy
1,013,737
+58,924
+6% +$2.89M 0.84% 21
2018
Q2 		$44.8M Buy
954,813
+201,889
+27% +$8.36M 0.73% 35
2018
Q1 		$26.7M Buy
+752,924
New +$29.5M 0.45% 86
2017
Q4 		– Sell
-838,821
Closed -$43.9M – 275
2017
Q3 		$43.9M Sell
838,821
-2,115
-0.3% -$118K 0.73% 39
2017
Q2 		$49.2M Sell
840,936
-24,771
-3% -$1.29M 0.85% 26
2017
Q1 		$39.7M Sell
865,707
-4,580
-0.5% -$228K 0.75% 41
2016
Q4 		$45.8M Sell
870,287
-79,462
-8% -$3.85M 0.89% 26
2016
Q3 		$42.3M Buy
+949,749
New +$41.2M 0.8% 32

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GW&K Investment Management's SYNH Position: Q3 2023 in Review

GW&K Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 125 shares — an estimated $6K sold.

GW&K Investment Management first reported a position in SYNH in Q3 2016 and held it in 27 quarters. The position peaked at $166M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • GW&K Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • GW&K Investment Management sold 125 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $6K.
  • GW&K Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 27 quarters.
  • GW&K Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $166M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on GW&K Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.